✦ LIBER ✦

Chronic Myeloid Leukemia and Second-Generation Tyrosine Kinase Inhibitors: When, How, and Which One?

✍ Scribed by Elias Jabbour; Hagop Kantarjian; Jorge Cortes

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Second-generation tyrosine kinase inhibi

✍ Ronan Swords; Yesid Alvarado; Jorge Cortes; Francis J. Giles 📂 Article 📅 2007 🏛 Current Science Inc. 🌐 English ⚖ 145 KB

How Much and How Long: Tyrosine Kinase I

✍ Elie Traer; Michael W. Deininger 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 193 KB

Outcome of Treatment of Chronic Myeloid

✍ A. Megan Cornelison; Hagop Kantarjian; Jorge Cortes; Elias Jabbour 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 414 KB

Sustained complete molecular response of

✍ Aoki, Jun; Ohashi, Kazuteru; Kobayashi, Takeshi; Kakihana, Kazuhiko; Hirashima, 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 229 KB

Survival outcomes for clonal evolution i

✍ Dushyant Verma; Hagop Kantarjian; Jianqin Shan; Susan O'Brien; Zeev Estrov; Guil 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB

Adverse cutaneous reactions to the new s

✍ Delgado, Livia; Giraudier, Stephane; Ortonne, Nicolas; Zehou, Ouidad; Cordonnier 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 67 KB